Today's Pre-Market Stock Movers and Top Ratings: ORCL, UPS, RTX, WRK and More

$Apple(AAPL.US)$ stock rose 0.2% ahead of the iPhone maker's latest hardware update in California later in the session, which is expected to see the launch of the iPhone 15.

$Boeing(BA.US)$ stock rose 0.1% after SMBC Aviation Capital, the world's second largest aircraft leasing firm, said it had concluded an order for 25 Boeing 737 MAX aircraft in a deal worth more than $3.7 billion at current list prices.

$Geron(GERN.US)$ stock rose 7.3% after Goldman Sachs upgraded its stance to ‘buy’ from ‘neutral’, citing the potential for the company's new drug application for imetelstat, aimed at treating lower-risk MDS.

$WestRock(WRK.US)$ stock jumped 6.9% after the company agreed to merge with Smurfit Kappa, to create the world's largest listed paper and packaging company worth nearly $20 billion.

$Oracle(ORCL.US)$ stock fell 10% after the computer software company disappointed with its current-quarter revenue guidance, with the firm attributing this to the accelerated transition of its recent acquisition Cerner (NASDAQ:CERN) to the cloud.

$United Parcel Service(UPS.US)$ stock fell 1.2% after the delivery giant stated that its new five-year contract covering some 340,000 Teamsters-represented workers in the United States would increase wage and benefit costs at a 3.3% compound annual growth rate over the life of the agreement.

$Acelyrin(SLRN.US)$ stock slumped over 50% after the drug maker’s experimental lead drug failed to show it was effective enough in reducing symptoms of an inflammatory skin disease.

$Sight Sciences(SGHT.US)$ stock fell over 30% after the manufacturer of ophthalmology surgical devices cut its revenue outlook, citing uncertainty about the future of Medicare coverage for its products.

$BeiGene(BGNE.US)$ initiated at Outperform by RBC Capital, announced target price at $259.

$Guess(GES.US)$ initiated at Buy by B. Riley Securities, announced target price at $31.

$Cintas(CTAS.US)$ was upgraded by BofA Securities from Neutral to Buy, increased target price from $523 to $580.

$CVS Health(CVS.US)$ was upgraded by Wolfe Research from Peer Perform to Outperform, increased target price to $80.

$RTX Corp(RTX.US)$ was downgraded by RBC Capital from Outperform to Sector Perform, decreased target price from $105 to $82.